Impact of Achievement of Complete Cytogenetic Response on Outcome in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents

We reviewed 216 consecutive patients with MDS and abnormal karyotype treated with hypomethylating agents between 4/04 and 10/12. Median follow-up was 17 months. Using IWG criteria, best responses were complete response (CR) in 79 patients (37%), partial response (PR) in 4 (2%), and hematologic impro...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Am J Hematol
मुख्य लेखकों: Jabbour, Elias, Strati, Paolo, Cabrero, Monica, O’Brien, Susan, Ravandi, Farhad, Bueso-Ramos, Carlos, Wei, Qiao, Hu, Jianhua, Aad, Simon Abi, Short, Nicholas J, Dinardo, Courtney, Daver, Naval, Kadia, Tapan, Wierda, William, Wei, Yue, Colla, Simona, Borthakur, Gautam, Cortes, Jorge, Estrov, Zeev, Kantarjian, Hagop, Garcia-Manero, Guillermo
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2017
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5439522/
https://ncbi.nlm.nih.gov/pubmed/28076892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24650
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन